Virus safety of plasma products using 20 nm instead of 15 nm filtration as virus removing step.

Koenderman, A H L; ter Hart, H G J; Prins-de Nijs, I M M; Bloem, J; Stoffers, S; Kempers, A; Derksen, G J; Al, B; Dekker, L; Over, J

Koenderman, A H L; ter Hart, H G J; Prins-de Nijs, I M M; Bloem, J; Stoffers, S; Kempers, A; Derksen, G J; Al, B; Dekker, L; Over, J.

Affiliation

Koenderman AH; Sanquin Blood Supply, Division of Plasma Products, Product Development, PO Box 9190, 1006 AD Amsterdam, The Netherlands. a.koenderman@sanquin.nl

Biologicals ; 40(6): 473-81, 2012 Nov.

Article in En | MEDLINE | ID: mdl-22901944

Subject(s)

Blood Substitutes; Blood-Borne Pathogens/isolation & purification; Filtration/instrumentation; Viruses/isolation & purification; Complement C1 Inactivator Proteins/analysis; Complement C1 Inhibitor Protein; Immunoglobulin G/analysis; Prothrombin/analysis; Transferrin/analysis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viruses / Blood Substitutes / Blood-Borne Pathogens / Filtration Language: En Journal: Biologicals Journal subject: ALERGIA E IMUNOLOGIA Year: 2012 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google